FDA and Ce Mark Approvals Driving the Adoption of Surgical Sealants and Adhesives

Growth in this market is majorly attributed to factors such as increasing need to manage blood loss in patients, growing rate of surgeries being performed annually, greater uptake of technologically advanced products, and increasing FDA and CE Mark approvals. Moreover, factors like rising geriatric population, increasing prevalence and incidence of chronic disorders, and increasing trauma and accident cases are driving the adoption of these sealants and adhesives.

"Surgical Sealants and Adhesives Market witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 9.6% between 2016 and 2021 to reach 2.96 Billion by 2021."

The Surgical Sealants and Adhesives Market is segmented on the basis of product, indication, application, and region. 

In 2016, North America is expected to account for the largest share of the market. The largest share of this regional segment is driven by rising healthcare expenditure, the presence of many large and well-equipped hospitals, greater uptake of technologically advanced medical products, increasing FDA approvals for surgical sealants, and the presence of major market players in this region. 

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=38230314

However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to growing per capita income, increasing medical tourism, the presence of less stringent regulations, and growing demand for quality healthcare. In addition, increasing investments by major players in this region is propelling the market further.

Target Audience:

• Medical Device Companies
• Pharmaceutical and Biotechnology Companies
• Life Sciences Companies
• Hospitals and Clinics
• Academic Research Institutes
• Government Institutes
• Market Research and Consulting Firms
• Venture Capitalists and Investors

Baxter International, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc.; U.S.), CryoLife, Inc. (U.S.), and C.R. Bard, Inc. (U.S.) held the major share of the Surgical Sealants and Adhesives Market and will continue to dominate the market between 2016 and 2021.

Some of the major players operating in this market are Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis Ltd. (Israel).